查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1362934

細胞培養市場規模、佔有率和趨勢分析報告：按產品、應用、地區和細分市場分類的趨勢，2023-2030年

Cell Culture Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Application (Biopharmaceutical Production, Diagnostics, Cell & Gene Therapy), By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

細胞培養市場的成長與趨勢：

根據Grand View Research, Inc.最新報告，預計到2030年，全球細胞培養市場規模將達到390.9億美元，2023年至2030年年複合成長率為11.32%。

新型3D細胞培養技術以及生物製藥開發、疫苗生產不斷成長的需求以及全球對先進治療藥物不斷成長的需求預計將在預測期內推動市場發展。 COVID-19大流行加速了疫苗開發活動，特別是在新型 mRNA 和 DNA 疫苗領域。大規模疫苗生產對使用細胞培養技術生產的載體產生了高的需求。例如，2023年2月，SK Bioscience宣布其首款基於細胞培養的四價流感疫苗SKYCellflu已在南美洲由智利公共衛生研究所（Instituto de Salud Publica de Chile，ISP）正式批准宣布。

此外，疫苗開發需要使用基於細胞的測定進行多個表達分析、品管和安全測試步驟。因此，近年來，細胞培養產品在此類應用中的使用需求量很大。此外，感染疾病發病率的增加、對疾病爆發預防的日益關注以及對疫苗技術的高研發投資預計將吸引疫苗生產並促進市場成長。在生物製藥領域，培養哺乳動物細胞的能力使得大量生產複雜的蛋白質為基礎的藥物成為可能。

這提高了生物製藥行業的效率、降低了成本並改善了品管。此外，高產細胞株的推出和培養條件的最佳化也有助於提高生產力和可擴展性。例如，2023年6月，Matica Bio在BIO國際大會上宣布了MatiMax細胞株。此外，一些公司採取市場擴張等策略性配合措施，這有助於市場成長。例如，2021年 3月，Thermo Fisher Scientific, Inc.宣布了一項擴張計劃，到2022年將投資 6 億美元的資本支出。該公司位於蘇格蘭、佛羅裡達和紐約的細胞培養基和製程流體工廠提高了 Gibco 細胞培養基、製程流體和補充劑的生產能力。這些新興市場的發展預計將在預測期內推動市場成長。

細胞培養市場報告亮點

  • 由於製藥和生物製藥公司生產單株抗體、疫苗、細胞和基因治療等先進生物製藥的研發費用增加，消耗品市場在2022年佔據最大佔有率，為57.44%。
  • 生物製藥生產領域佔比最大，2022年為32.15%。生物技術領域預計將擴大，推動預測期內對細胞培養用品和設備的需求。
  • 2022年，北美市場佔據主導地位，佔有率為 35.90%。這一巨大佔有率歸因於該地區完善的製藥和生物技術部門以及美國擴大採用先進技術的解決方案。此外，細胞培養技術的市場也很大，因為多所大學該地區進行大規模的細胞治療研究。
  • 由於人們對細胞和基因療法的認知不斷提高、科學以及再生醫學和癌症免疫療法等新興療法的迅速採用，預計亞太地區在預測期內將以 13.79%的年複合成長率成長最快。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 產業分析工具
    • 波特五力分析
    • PESTEL分析
    • COVID-19感染疾病的影響分析

第4章 產品經營分析

  • 細胞培養市場：產品波動分析
  • 消耗品
    • 2018-2030年全球消耗品市場
    • 媒體
    • 血清
    • 試劑
  • 裝置
    • 2018-2030年全球設備市場
    • 文化體系
    • 培養箱
    • 離心機
    • 冷凍儲存裝置
    • 生物安全設備
    • 移液器設備

第5章 商業分析的應用

  • 細胞培養市場：應用變化分析
  • 生物製藥生產
  • 藥物開發
  • 診斷
  • 組織培養與工程
  • 細胞和基因治療
  • 毒性試驗
  • 其他用途

第6章 區域業務分析

  • 2022年及2030年細胞培養市場佔有率（依地區）
  • 北美洲
    • 北美細胞培養市場，2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲細胞培養市場，2018-2030
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太細胞培養市場，2018-2030
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 拉丁美洲細胞培養市場，2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東、非洲
    • 中東和非洲細胞培養市場，2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 公司分類
  • 策略規劃
  • 2022年公司市場佔有率分析
  • 公司簡介/名單
    • Sartorius AG
    • Danaher
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Corning Inc.
    • Avantor Inc.
    • BD
    • Eppendorf SE
    • Bio-Techne
    • PromoCell GmbH
Product Code: 978-1-68038-536-6

Cell Culture Market Growth & Trends:

The global cell culture market size is expected to reach USD 39.09 billion by 2030 and is expected to grow at a CAGR of 11.32% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The novel three-dimensional cell culture techniques and the growing need for them in biopharmaceutical development, vaccine production, and the rising global demand for advanced therapy medicinal products are expected to drive the market during the forecast period. The COVID-19 pandemic has increased vaccine development activities, especially in the novel mRNA and DNA vaccines space. Vaccine production at a large scale generates a high demand for vectors produced using cell culture techniques. For instance, in February 2023, SK Bioscience announced that its first cell culture-based quadrivalent influenza vaccine, SKYCellflu, was officially licensed in South America by Instituto de Salud Publica de Chile (Institute of Public Health, ISP).

Furthermore, vaccine development requires several expression analyses, quality control, and safety testing procedures, which use cell-based assays. As a result, the usage of cell culture products for such applications has witnessed high demand in recent years. In addition, with an increase in the incidence of infectious diseases, a rise in focus on prevention of disease outbreaks, and high R&D investments in vaccine technologies, vaccine production is projected to gain traction and boost market growth.Moreover, cell culture technology has witnessed significant advancements over the past few years and the technology is witnessing a rapid expansion in its scope of applications. In the field of biopharmaceuticals, researchers can now produce complex protein-based drugs in large quantities due to the ability to culture mammalian cells.

This has led to increased efficiency, reduced costs, and improved quality control in the biopharmaceutical industry. Furthermore, the launch of high-yield cell lines and the optimization of culture conditions have contributed to enhanced productivity and scalability. For instance, in June 2023, Matica Bio launched its MatiMax cell lines at the BIO International Convention.Furthermore, several companies are engaged in strategic initiatives, such as market expansion, which can be attributed to market growth. For instance, in March 2021, Thermo Fisher Scientific, Inc. announced its expansion plans by investing USD 600 million into capital investments through 2022. Its cell culture media and process liquid sites in Scotland, Florida, and New York increased the production capacity of Gibco cell culture media, process liquids, and supplements. Such developments are expected to propel the market growth over the forecast period.

Cell Culture Market Report Highlights:

  • The consumables product segment accounted for the largest share of 57.44% in 2022 due to increased R&D spending by pharmaceutical & biopharmaceutical businesses to produce advanced biopharmaceuticals, such as monoclonal antibodies, vaccines, and cell & gene therapies
  • The biopharmaceutical production segment accounted for the largest share of 32.15% in 2022. The biotechnology sector is anticipated to expand, fueling demand for cell culture supplies and instruments over the forecast period
  • North America dominated the market with a share of 35.90% in 2022. The large share can be attributed to the region's well-established pharmaceutical & biotech sectors and higher adoption of technologically advanced solutions in the U.S. In addition, there is a large market for cell culture technologies in the region due to the extensive cell therapy research efforts undertaken by several universities
  • Asia Pacific is projected to expand at the fastest CAGR of 13.79% over the forecast period due to the rising awareness regarding cell and gene therapies, and the rapid adoption of scientific technologies and emerging therapeutics, such as regenerative medicines and cancer immunotherapies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Product Segment
      • 1.1.1.2. Application Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Objective
    • 1.4.1. Objective 1
    • 1.4.2. Objective2
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
    • 1.6.3. Secondary Sources
    • 1.6.4. Primary Research
  • 1.7. Information or Data Analysis:
    • 1.7.1. Data Analysis Models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity Flow Analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Abbreviations

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Expansion in the scope of cell culture technology
      • 3.2.1.2. Rising demand for biopharmaceuticals, artificial organs, & vaccine production
      • 3.2.1.3. Growth in demand for serum-free, specialty, and customized media
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent process control in cell culture techniques
      • 3.2.2.2. Scalability issues with culturing methods
      • 3.2.2.3. Ethical concerns regarding use of animals
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Product Business Analysis

  • 4.1. Cell Culture Market: Product Movement Analysis
  • 4.2. Consumables
    • 4.2.1. Global Consumables Market, 2018 - 2030 (USD Million)
    • 4.2.2. Media
      • 4.2.2.1. Global media market, 2018 - 2030 (USD million)
      • 4.2.2.2. Serum-free media
      • 4.2.2.2.1. Global serum-free media market, 2018 - 2030 (USD million)
      • 4.2.2.2.2. CHO media
      • 4.2.2.2.2.1. Global CHO media market, 2018 - 2030 (USD million)
      • 4.2.2.2.3. BHK medium
      • 4.2.2.2.3.1. Global BHK medium market, 2018 - 2030 (USD million)
      • 4.2.2.2.4. Vero medium
      • 4.2.2.2.4.1. Global Vero medium market, 2018 - 2030 (USD million)
      • 4.2.2.2.5. HEK 293 Media
      • 4.2.2.2.5.1. Global HEK 293 media market, 2018 - 2030 (USD million)
      • 4.2.2.2.6. Other serum-free media
      • 4.2.2.2.6.1. Global other serum-free media market, 2018 - 2030 (USD million)
      • 4.2.2.3. Classical media
      • 4.2.2.3.1. Global classical media market, 2018 - 2030 (USD million)
      • 4.2.2.4. Stem cell culture media
      • 4.2.2.4.1. Global stem cell culture media market, 2018 - 2030 (USD million)
      • 4.2.2.5. Specialty media
      • 4.2.2.5.1. Global specialty media market, 2018 - 2030 (USD million)
      • 4.2.2.6. Chemically defined media
      • 4.2.2.6.1. Global chemically defined media market, 2018 - 2030 (USD million)
      • 4.2.2.7. Other cell culture media
      • 4.2.2.7.1. Global other cell culture media market, 2018 - 2030 (USD million)
    • 4.2.3. Sera
      • 4.2.3.1. Global sera market, 2018 - 2030 (USD million)
      • 4.2.3.2. Fetal bovine serum
      • 4.2.3.2.1. Global fetal bovine serum market, 2018 - 2030 (USD million)
      • 4.2.3.3. Others
      • 4.2.3.3.1. Global others market, 2018 - 2030 (USD million)
    • 4.2.4. Reagents
      • 4.2.4.1. Global reagents market, 2018 - 2030 (USD million)
      • 4.2.4.2. Albumin
      • 4.2.4.2.1. Global albumin market, 2018 - 2030 (USD million)
      • 4.2.4.3. Others
      • 4.2.4.3.1. Global others market, 2018 - 2030 (USD million)
  • 4.3. Instruments
    • 4.3.1. Global instruments market, 2018 - 2030 (USD million)
    • 4.3.2. Culture systems
      • 4.3.2.1. Global culture systems market, 2018 - 2030 (USD million)
    • 4.3.3. Incubators
      • 4.3.3.1. Global incubators market, 2018 - 2030 (USD million)
    • 4.3.4. Centrifuges
      • 4.3.4.1. Global centrifuges market, 2018 - 2030 (USD million)
    • 4.3.5. Cryostorage equipment
      • 4.3.5.1. Global cryostorage equipment market, 2018 - 2030 (USD million)
    • 4.3.6. Biosafety equipment
      • 4.3.6.1. Global biosafety equipment market, 2018 - 2030 (USD million)
    • 4.3.7. Pipetting instruments
      • 4.3.7.1. Global pipetting instruments market, 2018 - 2030 (USD million)

Chapter 5. Application Business Analysis

  • 5.1. Cell Culture Market: Application Movement Analysis
  • 5.2. Biopharmaceutical Production
    • 5.2.1. Global Biopharmaceutical Production Market, 2018 - 2030 (USD Million)
    • 5.2.2. Monoclonal antibodies
      • 5.2.2.1. Monoclonal antibodies market, 2018 - 2030 (USD million)
    • 5.2.3. Vaccines production
      • 5.2.3.1. Global vaccines production market, 2018 - 2030 (USD million)
    • 5.2.4. Other therapeutic proteins
      • 5.2.4.1. Global other therapeutic proteins market, 2018 - 2030 (USD million)
  • 5.3. Drug Development
    • 5.3.1. Global drug development market, 2018 - 2030 (USD Million)
  • 5.4. Diagnostics
    • 5.4.1. Global diagnostics market, 2018 - 2030 (USD Million)
  • 5.5. Tissue Culture & Engineering
    • 5.5.1. Global tissue culture & engineering, 2018 - 2030 (USD Million)
  • 5.6. Cell & Gene Therapy
    • 5.6.1. Global cell and gene therapy market, 2018 - 2030 (USD million)
  • 5.7. Toxicity Testing
    • 5.7.1. Global toxicity testing market, 2018 - 2030 (USD million)
  • 5.8. Other Applications
    • 5.8.1. Global other applications market, 2018 - 2030 (USD million)

Chapter 6. Regional Business Analysis

  • 6.1. Cell Culture Market Share By Region, 2022 & 2030
  • 6.2. North America
    • 6.2.1. North America Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Competitive Scenario
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. U.S. Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Competitive Scenario
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Canada Cell Culture Market, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. UK Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Germany Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. France Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Competitive Scenario
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Italy Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Competitive Scenario
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Spain Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Competitive Scenario
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Denmark Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Competitive Scenario
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Sweden Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Competitive Scenario
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Norway Cell Culture Market, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Japan Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. China Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. India Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Australia Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Thailand Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. South Korea Cell Culture Market, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Brazil Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Mexico Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.5.4. Argentina
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Argentina Cell Culture Market, 2018 - 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. MEA Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. South Africa Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Saudi Arabia Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. UAE Cell Culture Market, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Kuwait Cell Culture Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Share Analysis, 2022
  • 7.4. Company Profiles/Listing
    • 7.4.1. Sartorius AG
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. Danaher
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Merck KGaA
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Thermo Fisher Scientific, Inc.
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Corning Inc.
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. Avantor Inc.
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. BD
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. Eppendorf SE
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Bio-Techne
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. PromoCell GmbH
      • 7.4.10.1. Overview
      • 7.4.10.2. Product Benchmarking
      • 7.4.10.3. Strategic Initiatives

List of Tables

  • Table 1 Global cell culture market, by region, 2018 - 2030 (USD Million)
  • Table 2 Global cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 6 U.S. cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 8 Canada cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 9 Canada cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 11 Europe cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 12 UK cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 13 UK cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 14 Germany cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 15 Germany cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 16 France cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 17 France cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 18 Italy cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 20 Spain cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 22 Denmark cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 23 Denmark cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 24 Sweden cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 25 Sweden cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 26 Norway cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 27 Norway cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific cell culture market, by application, 2018 - 2030 (USD Millon)
  • Table 30 Japan cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 31 Japan cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 32 China cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 33 China cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 34 India cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 35 India cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 36 Australia cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 37 Australia cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 38 South Korea cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 39 South Korea cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 40 Thailand cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 41 Thailand cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 42 Latin America cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 43 Latin America cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 44 Brazil cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 45 Brazil cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 46 Mexico cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 47 Mexico cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 48 Argentina cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 49 Argentina cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 50 Middle East & Africa cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 51 Middle East & Africa cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 52 South Africa cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 53 South Africa cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 54 Saudi Arabia cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 55 Saudi Arabia cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 56 UAE cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 57 UAE cell culture market, by application, 2018 - 2030 (USD Million)
  • Table 58 Kuwait cell culture market, by product, 2018 - 2030 (USD Million)
  • Table 59 Kuwait cell culture market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Cell culture market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Life science tools market value, 2022 (USD billion)
  • Fig. 16 Market trends & outlook
  • Fig. 17 Number of biologics approved by the U.S. FDA each year from 2015 to 2022
  • Fig. 18 PESTEL analysis
  • Fig. 19 Porter's five forces analysis
  • Fig. 20 Cell culture market: Product outlook & key takeaways
  • Fig. 21 Cell culture market: Product movement analysis
  • Fig. 22 Global consumables market, 2018 - 2030 (USD Million)
  • Fig. 23 Global media market, 2018 - 2030 (USD Million)
  • Fig. 24 Global serum-free media market, 2018 - 2030 (USD Million)
  • Fig. 25 Global CHO media market, 2018 - 2030 (USD Million)
  • Fig. 26 Global BHK medium market, 2018 - 2030 (USD Million)
  • Fig. 27 Global Vero medium market, 2018 - 2030 (USD Million)
  • Fig. 28 Global HEK 293 media market, 2018 - 2030 (USD Million)
  • Fig. 29 Global other serum-free media market, 2018 - 2030 (USD Million)
  • Fig. 30 Global classical media market, 2018 - 2030 (USD Million)
  • Fig. 31 Global stem cell culture media market, 2018 - 2030 (USD Million)
  • Fig. 32 Global specialty media market, 2018 - 2030 (USD Million)
  • Fig. 33 Global chemically defined media market, 2018 - 2030 (USD Million)
  • Fig. 34 Global other cell culture media market, 2018 - 2030 (USD Million)
  • Fig. 35 Global sera market, 2018 - 2030 (USD Million)
  • Fig. 36 Global fetal bovine serum market, 2018 - 2030 (USD Million)
  • Fig. 37 Global others market, 2018 - 2030 (USD Million)
  • Fig. 38 Global reagents market, 2018 - 2030 (USD Million)
  • Fig. 39 Global albumin market, 2018 - 2030 (USD Million)
  • Fig. 40 Global others market, 2018 - 2030 (USD Million)
  • Fig. 41 Global instruments market, 2018 - 2030 (USD Million)
  • Fig. 42 Global culture systems market, 2018 - 2030 (USD Million)
  • Fig. 43 Global incubators market, 2018 - 2030 (USD Million)
  • Fig. 44 Global centrifuges market, 2018 - 2030 (USD Million)
  • Fig. 45 Global cryostorage equipment market, 2018 - 2030 (USD Million)
  • Fig. 46 Global biosafety equipment market, 2018 - 2030 (USD Million)
  • Fig. 47 Global pipetting instruments market, 2018 - 2030 (USD Million)
  • Fig. 48 Cell culture market: Application outlook key takeaways
  • Fig. 49 Cell culture market: Application movement analysis
  • Fig. 50 Global biopharmaceutical production market, 2018 - 2030 (USD Million)
  • Fig. 51 Global monoclonal antibodies market, 2018 - 2030 (USD Million)
  • Fig. 52 Global vaccines production market, 2018 - 2030 (USD Million)
  • Fig. 53 Global other therapeutic proteins market, 2018 - 2030 (USD Million)
  • Fig. 54 Global drug development market, 2018 - 2030 (USD Million)
  • Fig. 55 Global diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 56 Global tissue culture & engineering market, 2018 - 2030 (USD Million)
  • Fig. 57 Global cell and gene therapy market, 2018 - 2030 (USD Million)
  • Fig. 58 Global toxicity testing market, 2018 - 2030 (USD Million)
  • Fig. 59 Global other applications market, 2018 - 2030 (USD Million)
  • Fig. 60 Regional outlook
  • Fig. 61 Regional marketplace: Key takeaways
  • Fig. 62 North America cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 U.S. cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Canada cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Europe cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Germany cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 UK cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 France cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 Italy cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Spain cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Denmark cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 Sweden cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 Norway cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Asia Pacific cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 85 Key country dynamics
  • Fig. 86 Japan cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 China cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 India cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Key country dynamics
  • Fig. 92 Australia cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Thailand cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 South Korea cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Latin America cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 98 Key country dynamics
  • Fig. 99 Brazil cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 100 Key country dynamics
  • Fig. 101 Mexico cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Key country dynamics
  • Fig. 103 Argentina cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 104 MEA cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 105 Key country dynamics
  • Fig. 106 South Africa cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 107 Key country dynamics
  • Fig. 108 Saudi Arabia cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 109 Key country dynamics
  • Fig. 110 UAE cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 111 Key country dynamics
  • Fig. 112 Kuwait cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 113 Market participant categorization
  • Fig. 114 Global cell culture market share analysis, 2022
  • Fig. 115 Strategic framework